Influence of polymeric subcoats on the drug release properties of tablets powder-coated with pre-plasticized Eudragit L 100-55
- PMID: 18848872
- DOI: 10.1016/j.ijpharm.2008.09.020
Influence of polymeric subcoats on the drug release properties of tablets powder-coated with pre-plasticized Eudragit L 100-55
Abstract
The aim of the study was to investigate the properties of sodium valproate tablets that were dry powder-coated with pre-plasticized Eudragit L 100-55. Polyethylene glycol 3350 (PEG 3350) was used as primer to facilitate initial coating powder adhesion. Solubility parameters were employed to determine the wetting properties of the PEG 3350 primer. Additional PEG 3350 within the powder coating formulation was required to enable powder adhesion to the tablet cores. The application of a subcoat of either Eudragit E PO or Eudragit RL PO facilitated adhesion of the enteric polymer to the tablet cores and reduced the amount PEG 3350 required in the coating formulation. Since reduction of the PEG 3350 content produced less water-vapor permeable films, the enteric coating level necessary to control the drug release was decreased. PEG 3350 and Methocel K4M were incorporated in both Eudragit E PO and Eudragit RL PO subcoating formulations as pore forming agents. The influence of the pore forming excipients on physicochemical properties of free powder-cast films was investigated. The miscibility of the PEG 3350 and Methocel K4M in the film coating was correlated with their ability to function as pore forming agent.
Similar articles
-
Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.Eur J Pharm Biopharm. 2007 Sep;67(2):464-75. doi: 10.1016/j.ejpb.2007.02.021. Epub 2007 Mar 7. Eur J Pharm Biopharm. 2007. PMID: 17451929
-
Sustained release coating of tablets with Eudragit(®) RS/RL using a novel electrostatic dry powder coating process.Int J Pharm. 2010 Oct 31;399(1-2):37-43. doi: 10.1016/j.ijpharm.2010.07.047. Epub 2010 Aug 1. Int J Pharm. 2010. PMID: 20678560
-
Crystal growth formation in melt extrudates.Int J Pharm. 2007 Aug 16;341(1-2):162-72. doi: 10.1016/j.ijpharm.2007.04.008. Epub 2007 Apr 19. Int J Pharm. 2007. PMID: 17524578
-
Techniques to assess film coatings and evaluate film-coated products.Drug Dev Ind Pharm. 2010 Feb;36(2):128-42. doi: 10.3109/03639040903433757. Drug Dev Ind Pharm. 2010. PMID: 20050727 Review.
-
Polymer blends for controlled release coatings.J Control Release. 2008 Jan 4;125(1):1-15. doi: 10.1016/j.jconrel.2007.09.012. Epub 2007 Oct 13. J Control Release. 2008. PMID: 18022722 Review.
Cited by
-
Highly Soluble Drugs Directly Granulated by Water Dispersions of Insoluble Eudragit® Polymers as a Part of Hypromellose K100M Matrix Systems.Biomed Res Int. 2019 Mar 5;2019:8043415. doi: 10.1155/2019/8043415. eCollection 2019. Biomed Res Int. 2019. PMID: 30949510 Free PMC article.
-
Sustained Release Drug Delivery Applications of Polyurethanes.Pharmaceutics. 2018 May 9;10(2):55. doi: 10.3390/pharmaceutics10020055. Pharmaceutics. 2018. PMID: 29747409 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous